Anticoagulation (AC) for stroke prevention in long‐term care (LTC) residents with atrial fibrillation (AF) involves a challenging risk‐benefit evaluation. We measured the association of geriatric conditions with discontinuation of AC. Click to show full abstract
Anticoagulation (AC) for stroke prevention in long‐term care (LTC) residents with atrial fibrillation (AF) involves a challenging risk‐benefit evaluation. We measured the association of geriatric conditions with discontinuation of AC.
               
Click one of the above tabs to view related content.